## ALLE: Allegion plc - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -4.7% below STRENGTH zone (4.0-10.0%); PEG 2.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($152.54)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Invesco Ltd. Reduces Stock Holdings in Allegion PLC $ALLE**
- Source: MarketBeat | 20251208T111954 | Neutral | Relevance: 98%
-  Invesco Ltd. has decreased its stake in Allegion PLC by 6.2% during the second quarter, selling 95,000 shares and reducing its total ownership to 1,427,784 shares, valued at $205,772,000. Despite this, other institutional investors like AQR Capital Management LLC and Kayne Anderson Rudnick Investment Management LLC have significantly increased their holdings in Allegion, with analyst ratings generally holding a "Hold" consensus for the stock. Allegion PLC reported strong third-quarter earnings, beating analyst estimates, and announced a quarterly dividend of $0.51 per share.

**2. Walleye Capital LLC Purchases New Position in Allegion PLC $ALLE**
- Source: MarketBeat | 20251206T130335 | Somewhat-Bullish | Relevance: 98%
-  Walleye Capital LLC has acquired a new position in Allegion PLC (NYSE:ALLE) during the second quarter, purchasing 57,151 shares valued at approximately $8.24 million. Other institutional investors have also adjusted their holdings, and analysts have provided varied ratings and price targets for Allegion's stock. The company recently reported strong quarterly earnings and declared a quarterly dividend.

**3. Allegion PLC $ALLE Shares Bought by Amundi**
- Source: MarketBeat | 20251209T080818 | Bullish | Relevance: 98%
-  Amundi significantly increased its stake in Allegion PLC by 30.4% in the second quarter, now holding 588,213 shares valued at approximately $87.03 million. Allegion exceeded Q2 earnings expectations with $2.30 EPS and $1.07 billion revenue, providing strong FY2025 guidance. The company also declared a quarterly dividend of $0.51, and its stock currently trades within a one-year range of $116.57â€“$180.68.

**4. 48,078 Shares in Allegion PLC $ALLE Purchased by Jump Financial LLC**
- Source: MarketBeat | 20251209T123003 | Somewhat-Bullish | Relevance: 98%
-  Jump Financial LLC recently acquired a new stake of 48,078 shares in Allegion PLC (NYSE:ALLE) during the second quarter, valued at approximately $6.93 million. Other hedge funds have also adjusted their holdings in Allegion. The article also provides details on Allegion's stock performance, recent earnings, dividend announcement, and analyst ratings, indicating a consensus "Hold" rating with an average target price of $176.38.

**5. Barclays Keeps Their Hold Rating on Allegion (ALLE)**
- Source: The Globe and Mail | 20251206T021027 | Neutral | Relevance: 98%
-  Barclays analyst Julian Mitchell maintained a Hold rating on Allegion (ALLE) and set a price target of $187.00. The company reported strong Q3 2025 earnings with increased revenue and net profit compared to the previous year, and corporate insider sentiment is positive with an increase in insider buying.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-1.0%)
- Blackrock Inc.: 8.6% (-13.5%)
- Boston Partners: 5.5% (+1.0%)
- Kayne Anderson Rudni: 5.1% (-2.3%)
- State Street Corpora: 4.9% (+6.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.9% 5d) with bearish MACD, trend may be turning.
2. Near-term weakness: 6.0% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.00 elevated, pricing in significant growth expectations. Forward P/E 17.9x stretched relative to 9% growth. Quality metrics strong (ROE 36%, ROA 10%, margin 16%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.7B |
| Beta | 1.04 |
| 52W Range | $116.57 - $180.68 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.00 |
| Forward P/E | 17.9 |
| Current P/E | 19.4 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.8% to -4.7% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >4.0% for momentum thesis). Underperforming sector by 4.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.66% (CS: 18) | Weak |
| RSI_14 | 34.8 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.973x | Below |
| vs SMA50 | 0.940x | Below |
| vs SMA200 | 1.043x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $158.86
- **Stop Loss:** $152.54 (4.0% risk)
- **Target:** $165.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $12,549.94
- **Portfolio %:** 12.55%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-17 (Est: $1.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.30 | +2.5% |
| 2025Q2 | $1.99 | $2.04 | +2.7% |
| 2025Q1 | $1.67 | $1.86 | +11.2% |
| 2024Q4 | $1.75 | $1.86 | +6.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*